The broad-based market anxiety increased as the US policy uncertainty rose, says Fidelity. The financial markets were weighed ...

Dependable, recurring dividends are a recipe for success. Here are four ultra-high-yield passive income stocks.

With uncertainty over tariffs, it is hard to know a value trap and a genuine attractive buying opportunity. Check out two ...

A couple of ETFs that may be attractive options for retirees are Schwab U.S. Dividend Equity ETF ( SCHD -1.16%) and Pacer ...

Are high-yield pharmaceutical stocks a good fit for you now? Why not meet with an experienced financial advisor who is near you for a portfolio review? Click here to get started finding one today.

Investors often hold blue ... chip stocks to buy for the long term. It benefits from numerous competitive advantages and has emerged as the clear e-commerce leader given its size and scale, which ...

The other deeply undervalued blue-chip stock that pays a very attractive ... These are the sorts of stocks that we are loading up on at High Yield Investor. Your timing is perfect!

Down 30% from all-time highs, CNQ is a blue-chip TSX dividend stock that offers you a yield of over 5% in April 2025.

Fidelity Blue Chip ... stocks. The strategy's underperformance follows a familiar pattern under longtime manager Sonu Kalra: When risk appetites shrink and the market punishes stocks with high ...

The ETF comprises 101 individual companies, primarily blue chip dividend stocks with established ... ETF like the Vanguard International High Dividend Yield ETF (NASDAQ: VYMI).

After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned ... Buy ratings on and pay among the highest dividends in the sector.